Chizuko Watanabe Selected Research

Chizuko Watanabe Research Topics

Disease

20	Pain (Aches) 08/2022 - 03/2007
4	Neuralgia (Stump Neuralgia) 08/2022 - 01/2009
4	Hyperalgesia 01/2021 - 01/2014
3	Dementia (Dementias) 08/2022 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 03/2016
2	Ejaculatory Dysfunction 02/2024 - 02/2009
2	Hypersensitivity (Allergy) 01/2022 - 01/2021
2	Cystitis 01/2022 - 01/2021
2	Cancer Pain 01/2014 - 01/2009
1	Retrograde Ejaculation 02/2024
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2022
1	Overactive Urinary Bladder (Overactive Bladder) 01/2022
1	Pruritus (Itching) 03/2021
1	Phototoxic Dermatitis (Phototoxicity) 03/2021
1	Dystonia musculorum deformans type 1 01/2021
1	Dystonia (Limb Dystonia) 01/2021
1	Nociceptive Pain 01/2021
1	Glaucoma 01/2020
1	Cognitive Dysfunction 01/2019
1	Chronic Pain 01/2019
1	Myoclonus (Nocturnal Myoclonus) 01/2014
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2009
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2008
1	Ischemia 01/2008

Drug/Important Bio-Agent (IBA)

6	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 09/2007
5	Analgesics (Analgesic Drugs)IBA 08/2022 - 02/2012
5	Volatile Oils (Essential Oils)IBA 03/2021 - 09/2018
4	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 02/2012
3	Gabapentin (Neurontin)FDA LinkGeneric 01/2021 - 01/2009
3	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 01/2009
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2020 - 01/2009
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020 - 01/2009
3	Freund's AdjuvantIBA 01/2020 - 01/2014
2	Antipsychotic Agents (Antipsychotics)IBA 08/2022 - 03/2021
2	LipopolysaccharidesIBA 01/2022 - 01/2021
2	LigandsIBA 01/2021 - 01/2021
2	hemokinin-1IBA 03/2016 - 08/2010
2	Glutamic Acid (Glutamate)FDA Link 05/2012 - 01/2008
2	Opioid Analgesics (Opioids)IBA 02/2012 - 01/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2024
1	Tamsulosin (Flomax)FDA LinkGeneric 02/2024
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2022
1	CytokinesIBA 01/2022
1	5-MethoxypsoralenIBA 03/2021
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2021
1	AntioxidantsIBA 01/2020
1	mesoglycanIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Narcotics (Narcotic Analgesics)IBA 02/2014
1	Ro 32-0432IBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2012
1	Formaldehyde (Formol)FDA Link 05/2012
1	Capsaicin (Zostrix)FDA Link 05/2012
1	Insulin (Novolin)FDA Link 02/2009
1	Streptozocin (Streptozotocin)FDA Link 02/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2009
1	Ketamine FDA LinkGeneric 01/2009
1	Retinaldehyde (Retinal)IBA 01/2008
1	N-Methylaspartate (NMDA)IBA 09/2007
1	substance P (1-7)IBA 09/2007
1	NociceptinIBA 03/2007

Therapy/Procedure

3	Aromatherapy 04/2020 - 09/2018
2	Intravesical Administration 01/2022 - 01/2021
2	Therapeutics 01/2019 - 01/2009
1	Off-Label Use 03/2021
1	Ligation 01/2021